These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 8987192

  • 1. Antibody response of Mexican infants to Haemophilus influenzae type b capsular polyribosylribitol phosphate. Differences between natural and vaccine induced (oligosaccharide-CRM197 conjugated vaccine) immunization.
    Massó F, Paéz A, Arista A, Salmón L, Montaño L.
    Arch Med Res; 1996; 27(4):539-45. PubMed ID: 8987192
    [Abstract] [Full Text] [Related]

  • 2. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ.
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ.
    Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216
    [Abstract] [Full Text] [Related]

  • 5. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
    Lee YC, Kelly DF, Yu LM, Slack MP, Booy R, Heath PT, Siegrist CA, Moxon RE, Pollard AJ.
    Clin Infect Dis; 2008 Jan 15; 46(2):186-92. PubMed ID: 18171249
    [Abstract] [Full Text] [Related]

  • 6. Safety and immunogenicity of haemophilus influenzae type B polysaccharide or conjugate vaccines in an elderly adult population.
    Lottenbach KR, Granoff DM, Barenkamp SJ, Powers DC, Kennedy D, Irby-Moore S, Homan SM, Mink CM.
    J Am Geriatr Soc; 2004 Nov 15; 52(11):1883-7. PubMed ID: 15507066
    [Abstract] [Full Text] [Related]

  • 7. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
    Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ.
    Southeast Asian J Trop Med Public Health; 1997 Mar 15; 28(1):91-8. PubMed ID: 9322290
    [Abstract] [Full Text] [Related]

  • 8. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
    Berrington JE, Cant AJ, Matthews JN, O'Keeffe M, Spickett GP, Fenton AC.
    Pediatrics; 2006 Apr 15; 117(4):e717-24. PubMed ID: 16549502
    [Abstract] [Full Text] [Related]

  • 9. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD, Ward JI, Chiu CE, Marcy SM, Gordon L, Hendley JO, Meier K, Marchant CD, McVerry P.
    Pediatrics; 1990 Mar 15; 85(3):288-93. PubMed ID: 2304781
    [Abstract] [Full Text] [Related]

  • 10. An enzyme-linked immunosorbent assay for quantitation of Haemophilus Influenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey sera.
    Dolan KT, Staub JM, Schofield TL, Ahonkhai VI, Ellis RW, Vella PP.
    J Immunoassay; 1991 Mar 15; 12(4):543-64. PubMed ID: 1806588
    [Abstract] [Full Text] [Related]

  • 11. Safety and immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM197 conjugate vaccine in infants aged 15 to 23 months.
    Madore DV, Johnson CL, Phipps DC, Myers MG, Eby R, Smith DH.
    Pediatrics; 1990 Oct 15; 86(4):527-34. PubMed ID: 2216616
    [Abstract] [Full Text] [Related]

  • 12. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphate-outer membrane protein conjugate vaccine.
    Munoz A, Salvador A, Brodsky NL, Arbeter AM, Porat R.
    Pediatrics; 1995 Aug 15; 96(2 Pt 1):216-9. PubMed ID: 7630672
    [Abstract] [Full Text] [Related]

  • 13. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI.
    Infect Immun; 1993 Dec 15; 61(12):5345-50. PubMed ID: 8225608
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of Haemophilus influenzae type b colonization by vaccination: correlation with serum anti-capsular IgG concentration.
    Fernandez J, Levine OS, Sanchez J, Balter S, LaClaire L, Feris J, Romero-Steiner S.
    J Infect Dis; 2000 Nov 15; 182(5):1553-6. PubMed ID: 11023481
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants.
    Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ.
    Vaccine; 2006 May 29; 24(22):4727-36. PubMed ID: 16616973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Responses to immunisation with Hib conjugate vaccine in Australian breastfed and formula-fed infants.
    Hawkes JS, Makrides M, Roberton DM, Gibson RA.
    J Paediatr Child Health; 2007 Sep 29; 43(9):597-600. PubMed ID: 17688643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.